Witnessing the stock’s movement on the chart, on January 03, 2022, Unity Biotechnology Inc. (NASDAQ: UBX) set off with pace as it heaved 19.86% to $1.75. During the day, the stock rose to $1.78 and sunk to $1.50 before settling in for the price of $1.46 at the close. Taking a more long-term approach, UBX posted a 52-week range of $1.23-$9.78.
Nevertheless, stock’s Earnings Per Share (EPS) this year is 2.10%. This publicly-traded company’s shares outstanding now amounts to $55.44 million, simultaneously with a float of $54.09 million. The organization now has a market capitalization sitting at $99.73 million. At the time of writing, stock’s 50-day Moving Average stood at $2.0921, while the 200-day Moving Average is $3.5988.
Unity Biotechnology Inc. (UBX) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Biotechnology industry. Unity Biotechnology Inc.’s current insider ownership accounts for 3.20%, in contrast to 48.90% institutional ownership.
Unity Biotechnology Inc. (UBX) Earnings and Revenue Records
As on 6/29/2021, Multinational firm has announced its last quarter scores, in which it reported -$0.32 earnings per share (EPS) for the period falling under the consensus outlook (set at -$0.31) by -$0.01. This company achieved a return on equity of -91.81. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.45 per share during the current fiscal year.
Unity Biotechnology Inc.’s EPS increase for this current 12-month fiscal period is 2.10% and is forecasted to reach -1.55 in the upcoming year.
Unity Biotechnology Inc. (NASDAQ: UBX) Trading Performance Indicators
Let’s observe the current performance indicators for Unity Biotechnology Inc. (UBX). It’s Quick Ratio in the last reported quarter now stands at 6.50. The Stock has managed to achieve an average true range (ATR) of 0.19.
In the same vein, UBX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.28, a figure that is expected to reach -0.34 in the next quarter, and analysts are predicting that it will be -1.55 at the market close of one year from today.
Technical Analysis of Unity Biotechnology Inc. (UBX)
During the previous 9 days, stock’s Stochastic %D was recorded 64.14% While, its Average True Range was 0.1908.
Raw Stochastic average of Unity Biotechnology Inc. (UBX) in the period of the previous 100 days is set at 21.22%, which indicates a major fall in contrast to 94.55% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 132.71% that was higher than 90.84% volatility it exhibited in the past 100-days period.